Abstract
Expression of the transcription repressor Gfi-1 is required for the maintenance of murine hematopoietic stem cells. In human cells, ectopic expression of Gfi-1 inhibits and RNA interference-mediated Gfi-1 downregulation enhances proliferation and colony formation of p210BCR/ABL expressing cells. To investigate the molecular mechanisms that may explain the effects of perturbing Gfi-1 expression in human cells, Gfi-1-regulated genes were identified by microarray analysis in K562 cells expressing the tamoxifen-regulated Gfi-1-ER protein. STAT 5B and Mcl-1, two genes important for the proliferation and survival of hematopoietic stem cells, were identified as direct and functionally relevant Gfi-1 targets in p210BCR/ABL-transformed cells because: (i) their expression and promoter activity was repressed by Gfi-1 and (ii) when constitutively expressed blocked the proliferation and colony formation inhibitory effects of Gfi-1. Consistent with these findings, genetic or pharmacological inhibition of STAT 5 and/or Mcl-1 markedly suppressed proliferation and colony formation of K562 and CD34 + chronic myelogenous leukemia (CML) cells. Together, these studies suggest that the Gfi-1STAT 5B/Mcl-1 regulatory pathway identified here can be modulated to suppress the proliferation and survival of p210BCR/ABL-transformed cells including CD34 + CML cells.
Original language | English |
---|---|
Pages (from-to) | 1555-1563 |
Number of pages | 9 |
Journal | Leukemia |
Volume | 26 |
Issue number | 7 |
DOIs | |
Publication status | Published - Jul 2012 |
Keywords
- cell survival
- oncogene
- tumor suppressor gene
- therapy
- HEMATOPOIETIC STEM-CELLS
- C/EBP-ALPHA EXPRESSION
- BINDING PROTEIN-ALPHA
- SELF-RENEWAL
- MYELOID-LEUKEMIA
- GRANULOCYTIC DIFFERENTIATION
- DOWN-REGULATION
- APOPTOSIS
- INDUCTION
- ACTIVATION